Click HERE to register

WEBINAR CONTENT DESCRIPTION:

Join us for the following:

• Overview of the scientific evidence involving Dupixent and Cutaneous T-Cell Lymphoma (CTCL).
• Identifying viable claims and potential pitfalls
• Procedural posture of cases nationwide and expected next steps in the MDL process.